News
All NewsAAP NewsPNP Corner
Media
Cure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Diabetes
  • Gastroenterology
    • Formula
    • Nutrition
    • Obesity
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
    • Vaccines
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement

Jonathan Strober, MD

Advertisement
Jonathan Strober, MD

Jonathan Strober, MD, Director of the Pediatric Neuromuscular Program and Professor of Pediatrics and Neurology at the University of California at San Francisco.

Articles by Jonathan Strober, MD

 Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

Jonathan Strober, MD, highlights 'encouraging' nipocalimab-aahu data for generalized myasthenia gravis

ByJoshua Fitch, Senior Editor ,Jonathan Strober, MD
November 26th 2025
Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contemporary Pediatrics

    1

    Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis

    2

    FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy

    3

    Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults

    4

    Managing Pediatric AD With New Topicals

    5

    Prepandemic diet quality similar among WIC participants and income-eligible nonparticipants

    • About Us
    • Advertise
    • Contact Us
    • Editorial
    • Job Board
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us